Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 months

Response to tyrosine kinase inhibitors at three months is a predictor for long-term outcome in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. We analyzed 456 newly diagnosed chronic myeloid leukemia patients treated with tyrosine kinase inhibitors to determine their outco...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Nazha, Aziz, Kantarjian, Hagop, Jain, Preetesh, Romo, Carlos, Jabbour, Elias, Quintas-Cardama, Alfonso, Luthra, Raja, Abruzzo, Lynne, Borthakur, Gautam, Ravandi, Farhad, Pierce, Sherry, O’Brien, Susan, Cortes, Jorge
פורמט: Artigo
שפה:Inglês
יצא לאור: Ferrata Storti Foundation 2013
נושאים:
Chronic Myeloid Leukemia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815167/
https://ncbi.nlm.nih.gov/pubmed/23812943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.090282
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים